StocksFundsScreenerSectorsWatchlists
BCPC

BCPC - Balchem Corp Stock Price, Fair Value and News

147.82USD-1.48 (-0.99%)Market Closed

Market Summary

BCPC
USD147.82-1.48
Market Closed
-0.99%

BCPC Alerts

  • 2 major insider sales recently.

BCPC Stock Price

View Fullscreen

BCPC RSI Chart

BCPC Valuation

Market Cap

4.8B

Price/Earnings (Trailing)

43.94

Price/Sales (Trailing)

5.17

EV/EBITDA

27.75

Price/Free Cashflow

25.96

BCPC Price/Sales (Trailing)

BCPC Profitability

Operating Margin

32.75%

EBT Margin

14.88%

Return on Equity

10.3%

Return on Assets

6.8%

Free Cashflow Yield

3.85%

BCPC Fundamentals

BCPC Revenue

Revenue (TTM)

922.4M

Rev. Growth (Yr)

-1.65%

Rev. Growth (Qtr)

-0.54%

BCPC Earnings

Earnings (TTM)

108.5M

Earnings Growth (Yr)

24.49%

Earnings Growth (Qtr)

-8.35%

Breaking Down BCPC Revenue

Last 7 days

-1.6%

Last 30 days

-4.8%

Last 90 days

5.0%

Trailing 12 Months

15.6%

How does BCPC drawdown profile look like?

BCPC Financial Health

Current Ratio

2.12

Debt/Equity

0.15

Debt/Cashflow

1.01

BCPC Investor Care

Shares Dilution (1Y)

0.30%

Diluted EPS (TTM)

3.35

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023946.0M940.6M926.3M922.4M
2022842.2M876.6M923.0M942.4M
2021714.9M743.9M766.6M799.0M
2020661.1M672.9M689.5M703.6M
2019639.3M637.2M640.7M643.7M
2018618.5M635.1M639.4M643.7M
2017555.8M564.1M576.3M594.8M
2016542.8M546.8M545.2M553.2M
2015600.3M602.8M582.4M552.5M
2014338.5M387.5M460.3M541.4M
2013318.8M323.1M335.6M337.2M
2012295.1M299.4M300.1M310.4M
2011268.2M281.4M291.9M291.9M
2010228.3M237.3M246.2M255.1M
2009000219.4M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Balchem Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 08, 2024
tignor michael brent
acquired
358,680
85.4
4,200
svp & chief hr officer
Mar 08, 2024
tignor michael brent
sold
-840,985
157
-5,339
svp & chief hr officer
Mar 04, 2024
wineinger matthew david
sold
-209,128
156
-1,333
-
Feb 26, 2024
backus william a.
sold
-1,086,300
155
-7,000
vp & chief accounting officer
Feb 23, 2024
backus william a.
sold
-1,435,470
156
-9,180
vp & chief accounting officer
Feb 23, 2024
backus william a.
acquired
738,421
80.438
9,180
vp & chief accounting officer
Feb 22, 2024
harris theodore l
sold
-5,300,030
154
-34,350
chairman, president & ceo
Feb 22, 2024
harris theodore l
acquired
2,030,400
59.1091
34,350
chairman, president & ceo
Feb 21, 2024
harris theodore l
sold
-4,558,030
153
-29,679
chairman, president & ceo
Feb 21, 2024
sestrick michael robert
acquired
871,999
78.5585
11,100
svp & chief technology officer

1–10 of 50

Which funds bought or sold BCPC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 11, 2024
CONGRESS ASSET MANAGEMENT CO /MA
added
7.7
4,346,190
39,995,100
0.28%
Apr 11, 2024
SALEM INVESTMENT COUNSELORS INC
unchanged
-
525,949
13,146,700
0.43%
Apr 10, 2024
AMERICAN NATIONAL BANK
sold off
-100
-893
-
-%
Apr 10, 2024
Laurus Investment Counsel Inc.
unchanged
-
243,436
4,007,040
1.41%
Apr 10, 2024
PARK AVENUE SECURITIES LLC
reduced
-1.34
12,000
445,000
0.01%
Apr 09, 2024
MATHER GROUP, LLC.
new
-
8,925
8,925
-%
Apr 09, 2024
Rise Advisors, LLC
new
-
13,946
13,946
0.01%
Apr 09, 2024
MASSMUTUAL TRUST CO FSB/ADV
added
2.6
787
12,241
-%
Apr 08, 2024
Bath Savings Trust Co
reduced
-1.55
145,227
5,841,460
0.62%
Apr 05, 2024
CWM, LLC
added
3.47
3,000
46,000
-%

1–10 of 49

Are Funds Buying or Selling BCPC?

Are funds buying BCPC calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own BCPC
No. of Funds

Unveiling Balchem Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
11.76%
3,791,512
SC 13G/A
Feb 09, 2024
wasatch advisors lp
-
0
SC 13G/A
Feb 07, 2024
apg asset management us inc.
9.0%
2,917,112
SC 13G/A
Jan 22, 2024
blackrock inc.
15.5%
4,989,247
SC 13G/A
Feb 09, 2023
wasatch advisors inc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
11.95%
3,841,468
SC 13G/A
Jan 26, 2023
blackrock inc.
15.5%
4,972,536
SC 13G/A
Jan 20, 2023
blackrock inc.
15.5%
4,972,536
SC 13G/A
Jan 12, 2023
apg asset management us inc.
8.5%
2,719,969
SC 13G/A
Feb 11, 2022
wasatch advisors inc
-
0
SC 13G

Recent SEC filings of Balchem Corp

View All Filings
Date Filed Form Type Document
Mar 29, 2024
8-K
Current Report
Mar 12, 2024
4
Insider Trading
Mar 08, 2024
144
Notice of Insider Sale Intent
Mar 06, 2024
4
Insider Trading
Mar 04, 2024
144
Notice of Insider Sale Intent
Feb 27, 2024
4
Insider Trading
Feb 26, 2024
144
Notice of Insider Sale Intent
Feb 23, 2024
4
Insider Trading
Feb 23, 2024
4
Insider Trading
Feb 23, 2024
4
Insider Trading

Peers (Alternatives to Balchem Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
51.5B
12.4B
-6.36% -19.63%
22.04
4.15
-3.54% 3.06%
40.7B
44.6B
-0.47% 1.37%
61.7
0.91
-21.58% -85.78%
17.0B
10.9B
-1.17% 40.56%
8.67
1.55
13.10% 3.48%
16.9B
7.0B
-1.73% 16.10%
52.7
2.43
-7.26% -53.23%
14.4B
9.6B
-2.54% -39.61%
9.15
1.5
31.38% -41.50%
11.5B
9.2B
5.32% 17.50%
12.86
1.25
-12.95% 12.74%
MID-CAP
5.2B
3.9B
7.13% 22.04%
11.63
1.32
-9.12% 26.64%
4.8B
922.4M
-4.80% 15.56%
43.94
5.17
-2.11% 3.01%
3.8B
3.1B
-0.86% 1.62%
49.49
1.2
-7.48% -89.19%
2.9B
3.1B
-6.37% 18.91%
6.24
0.92
-15.54% -65.21%
SMALL-CAP
1.2B
404.0M
0.11% 32.60%
36.59
3
24.06% -25.72%
733.4M
1.5B
0.99% -32.17%
13.43
0.48
-21.18% -60.55%
165.9M
357.7M
-4.38% -3.93%
8.16
0.46
-5.20% 66.55%
108.8M
21.4M
-13.13% 6.92%
12.95
5.09
-45.68% 139.98%
3.7M
-
-80.00% -99.58%
-0.01
0.01
- -

Balchem Corp News

Latest updates
Defense World38 hours ago
Yahoo Finance06 Mar 202408:00 am

Balchem Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue-0.5%229230231233233244237229213198202186181175173174167159162157164
Cost Of Revenue0.2%154153154159164176165157149137143127124119118119112105108108112
Gross Profit-2.0%75.0077.0077.0073.0069.0068.0072.0072.0064.0061.0059.0059.0057.0056.0055.0055.0054.0054.0054.0049.0051.00
Operating Expenses11.3%37.0033.0035.0039.0035.0035.0032.0033.0030.0028.0029.0028.0028.0027.0028.0029.0031.0028.0028.0023.0024.00
  S&GA Expenses5.6%19.0018.0019.0018.0018.0017.0016.0017.0015.0015.0015.0015.0015.0014.0014.0015.0016.0015.0015.0014.0014.00
  R&D Expenses1.8%4.004.004.003.003.003.003.003.005.003.003.003.002.003.003.003.003.003.003.003.003.00
EBITDA Margin5.1%0.18*0.17*0.17*0.17*0.19*0.20*0.21*0.21*0.21*0.22*0.22*0.22*---------
Interest Expenses19.8%-5.29-6.59-5.16-5.56-5.12-3.64-0.96-0.55-0.57-0.56-0.61-0.72-0.83-0.95-0.96-1.70-1.21-1.67-1.49-1.59-1.67
Income Taxes-10.6%7.007.008.006.004.006.009.009.008.007.007.007.006.006.005.005.002.004.005.006.005.00
Earnings Before Taxes-8.8%33.0036.0038.0029.0026.0031.0039.0038.0033.0032.0030.0030.0028.0028.0026.0024.0022.0024.0025.0025.0025.00
EBT Margin6.2%0.15*0.14*0.13*0.13*0.14*0.15*0.16*0.16*0.16*0.16*0.16*0.16*---------
Net Income-8.3%27.0029.0030.0023.0021.0025.0030.0029.0025.0025.0023.0023.0022.0022.0021.0020.0020.0021.0020.0019.0020.00
Net Income Margin5.5%0.12*0.11*0.11*0.10*0.11*0.12*0.12*0.12*0.12*0.12*0.12*0.12*---------
Free Cashflow44.9%67.0047.0029.0029.0035.0035.0042.001.0038.0033.0030.0034.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-0.4%1,5971,6031,6191,6291,6251,6331,6071,1951,1991,1791,1741,1691,1661,1611,1511,1621,1561,0971,098972981
  Current Assets-7.9%314341337336336368377320322300287281267270264271255240232222226
    Cash Equivalents-16.3%64.0077.0067.0060.0067.0056.0076.0064.0010390.0080.0089.0085.0079.0076.0074.0066.0059.0042.0039.0054.00
  Inventory-5.9%11011612512512013914110891.0082.0078.0077.0071.0077.0082.0083.0084.0074.0068.0067.0067.00
  Net PPE2.7%276269271276271260252240238230228227228220217215217201204188191
  Goodwill1.6%779767774774770749216523524525527526529526523523524504507446448
Liabilities-6.1%543578612655686737705321322290304320338342359396412363366261290
  Current Liabilities37.4%14810811411714014214412414410510189.0094.0068.0068.0072.0092.0072.0062.0064.0082.00
  Long Term Debt---------------------156
    LT Debt, Current-----------------2.00----
    LT Debt, Non Current---------------------156
Shareholder's Equity2.8%1,0541,0251,007973938896901874877889870849828819793766744734732711692
  Retained Earnings0.1%897896867837814816791761732728703680657653632611591587567547528
  Additional Paid-In Capital3.3%146141137132129125121117148173173171165175174174174174170167165
Shares Outstanding0.0%32.0032.0032.0032.0032.0032.0032.0032.0032.0032.0032.0032.00---------
Float---4,321---4,133---4,224---3,046---3,212--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations44.9%67,40646,52634,99134,83841,65541,62048,2407,02144,49139,63435,78240,60747,95435,36044,61522,56532,96742,68226,32922,48339,512
  Share Based Compensation1.0%3,7853,7493,7484,7703,3862,9493,8123,0771,9932,8953,2922,6221,5482,2542,3202,1811,8792,0951,9911,6311,205
Cashflow From Investing-27.9%-11,865-9,276-3,611-10,061-14,489-85,113-306,340-10,072-14,181-7,599-7,294-6,226-13,211-7,787-8,199-5,394-53,1164,566-101,895-5,780-5,642
Cashflow From Financing-179.5%-70,146-25,098-24,759-33,318-21,40128,386274,539-34,845-15,945-20,506-37,794-27,933-31,545-26,692-34,767-8,16025,760-28,66977,868-31,574-22,036
  Dividend Payments-100.0%-3.002.0022,8675.004.001.0020,70319.004.00-18,7001.00--16,704---15,1354.00
  Buy Backs339.6%44410175.003,84917846.0060034,59916,4777,9279,2391,5967,4812,9572,134891-20,594-727171

BCPC Income Statement

2023-12-31
Consolidated Statements of Earnings - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]   
Net sales$ 922,439$ 942,358$ 799,023
Cost of sales620,383661,907555,849
Gross margin302,056280,451243,174
Operating expenses:   
Selling expenses74,39767,40960,413
Research and development expenses15,04912,19113,524
General and administrative expenses53,41755,66541,735
Total operating expenses142,863135,265115,672
Earnings from operations159,193145,186127,502
Other expenses:   
Interest expense, net22,61310,2682,456
Other (income) expense, net(681)1,169(187)
Total other expenses21,93211,4372,269
Earnings before income tax expense137,261133,749125,233
Income tax expense28,71828,38229,129
Net earnings$ 108,543$ 105,367$ 96,104
Basic net earnings per common share (in dollars per share)$ 3.38$ 3.29$ 2.98
Diluted net earnings per common share (in dollars per share)$ 3.35$ 3.25$ 2.94

BCPC Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 64,447$ 66,560
Accounts receivable, net of allowance for doubtful accounts of $908 and $1,226 at December 31, 2023 and 2022, respectively125,284131,578
Inventories, net109,521119,668
Prepaid expenses7,7984,903
Derivative assets05,993
Other current assets7,1927,101
Total current assets314,242335,803
Property, plant and equipment, net276,039271,355
Goodwill778,907769,509
Intangible assets with finite lives, net191,212213,295
Right of use assets - operating leases17,76317,094
Right of use assets - finance lease2,1012,338
Other non-current assets16,94715,118
Total assets1,597,2111,624,512
Current liabilities:  
Trade accounts payable55,50357,322
Accrued expenses40,85536,745
Accrued compensation and other benefits17,22816,544
Dividends payable25,71723,129
Income tax payable4,9672,280
Operating lease liabilities - current3,9493,796
Finance lease liabilities - current272226
Total current liabilities148,491140,042
Revolving loan309,569440,569
Deferred income taxes52,04662,784
Operating lease liabilities - non-current14,60113,806
Finance lease liabilities - non-current1,9432,213
Other long-term obligations16,57726,814
Total liabilities543,227686,228
Commitments and contingencies (Note 16)
Stockholders’ equity:  
Preferred stock, $25 par value. Authorized 2,000,000 shares; none issued and outstanding00
Common stock, $.0667 par value. Authorized 120,000,000 shares; 32,254,728 shares issued and outstanding at December 31, 2023 and 32,152,787 shares issued and outstanding at December 31, 2022, respectively2,1522,145
Additional paid-in capital145,653128,806
Retained earnings897,488814,487
Accumulated other comprehensive income (loss)8,691(7,154)
Total stockholders’ equity1,053,984938,284
Total liabilities and stockholders’ equity$ 1,597,211$ 1,624,512
BCPC
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; single use canisters for sterilizing re-usable devices; and ammonia. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in Montvale, New Jersey.
 CEO
 WEBSITEbalchem.com
 INDUSTRYChemicals
 EMPLOYEES1284

Balchem Corp Frequently Asked Questions


What is the ticker symbol for Balchem Corp? What does BCPC stand for in stocks?

BCPC is the stock ticker symbol of Balchem Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Balchem Corp (BCPC)?

As of Fri Apr 12 2024, market cap of Balchem Corp is 4.77 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BCPC stock?

You can check BCPC's fair value in chart for subscribers.

What is the fair value of BCPC stock?

You can check BCPC's fair value in chart for subscribers. The fair value of Balchem Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Balchem Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for BCPC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Balchem Corp a good stock to buy?

The fair value guage provides a quick view whether BCPC is over valued or under valued. Whether Balchem Corp is cheap or expensive depends on the assumptions which impact Balchem Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BCPC.

What is Balchem Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 12 2024, BCPC's PE ratio (Price to Earnings) is 43.94 and Price to Sales (PS) ratio is 5.17. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BCPC PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Balchem Corp's stock?

In the past 10 years, Balchem Corp has provided 0.095 (multiply by 100 for percentage) rate of return.